These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9374560)

  • 1. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.
    Rodriguez WJ; Gruber WC; Groothuis JR; Simoes EA; Rosas AJ; Lepow M; Kramer A; Hemming V
    Pediatrics; 1997 Dec; 100(6):937-42. PubMed ID: 9374560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.
    Pediatrics; 1997 Jan; 99(1):93-9. PubMed ID: 8989345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus immune globulin: decisions and costs.
    Barton LL; Grant KL; Lemen RJ
    Pediatr Pulmonol; 2001 Jul; 32(1):20-8. PubMed ID: 11416872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children.
    Groothuis JR
    J Pediatr; 1994 May; 124(5 Pt 2):S28-32. PubMed ID: 8169755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus immune globulin intravenous.
    Wandstrat TL
    Ann Pharmacother; 1997 Jan; 31(1):83-8. PubMed ID: 8997472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ; Wang EE; MacDonald N; McDonald J; Dobson S; Boucher F; Langley J; Robinson J; Mitchell I; Stephens D
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children.
    Simoes EA; Groothuis JR; Tristram DA; Allessi K; Lehr MV; Siber GR; Welliver RC
    J Pediatr; 1996 Aug; 129(2):214-9. PubMed ID: 8765618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin treatment for respiratory syncytial virus infection.
    Fuller H; Del Mar C
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004883. PubMed ID: 17054220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
    Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP;
    Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection.
    Welliver RC
    Semin Perinatol; 1998 Feb; 22(1):87-95. PubMed ID: 9523402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of respiratory syncytial virus immune globulin in 1996-1997: a local controlled comparison.
    Redding GJ; Braun S; Mayock D
    Arch Pediatr Adolesc Med; 1999 May; 153(5):503-7. PubMed ID: 10323631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
    Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.
    Somers CC; Ahmad N; Mejias A; Buckingham SC; Carubelli C; Katz K; Leos N; Gomez AM; DeVincenzo JP; Ramilo O; Jafri HS
    Pediatr Allergy Immunol; 2009 Aug; 20(5):477-85. PubMed ID: 19397752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: Immunoglobulin treatment for respiratory syncytial virus infection.
    Fuller HL; Del Mar CB
    Cochrane Database Syst Rev; 2010 Sep; 2010(9):CD004883. PubMed ID: 20824840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants.
    Joffe S; Ray GT; Escobar GJ; Black SB; Lieu TA
    Pediatrics; 1999 Sep; 104(3 Pt 1):419-27. PubMed ID: 10469764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.
    Hemming VG; Prince GA; Groothuis JR; Siber GR
    Clin Microbiol Rev; 1995 Jan; 8(1):22-33. PubMed ID: 7704893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants.
    Pediatrics; 1998 Sep; 102(3):531-7. PubMed ID: 9724660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.